The Benefits of Olanzapine in Palliating Symptoms
- 26 November 2020
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 22 (1) , 1-20
Abstract
Opinion Statement Olanzapine has become a major drug in the management of chemotherapy-induced nausea and vomiting as a prophylactic agent. In addition, a recent randomized trial has demonstrated its benefits in treating nausea and vomiting associated with advanced cancer. The added benefit to olanzapine is that it also stimulates appetite. As a result, since it treats multiple symptoms associated with advanced cancer, it is likely to become the antiemetic of choice in palliative care at least in the USA. The added benefit of treating insomnia and the avoidance of benzodiazepines should place olanzapine in at the top of the list of drugs to use for patients who do complain of insomnia. There is no good evidence that it potentiates the respiratory depression of opioids unlike benzodiazepines. The evidence is weak that olanzapine in as an adjuvant analgesic. Hopefully, future trials will explore this in greater depth. The benefits of adding olanzapine to potent opioids are that it may reduce craving, drug cues, and opioid misuse. Other symptoms like anxiety and depression may be addressed by the addition of olanzapine to standard antidepressants.Keywords
This publication has 161 references indexed in Scilit:
- Dependence Potential of Quetiapine: Behavioral Pharmacology in RodentsBiomolecules & Therapeutics, 2013
- Promiscuous Dimerization of the Growth Hormone Secretagogue Receptor (GHS-R1a) Attenuates Ghrelin-mediated SignalingJournal of Biological Chemistry, 2013
- Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 AgonismNeuron, 2012
- Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapineTherapeutic Advances in Psychopharmacology, 2011
- Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphineSynapse, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- The effect of dopamine partial agonists on the nicotine dependency in patients with schizophreniaHuman Psychopharmacology: Clinical and Experimental, 2009
- Abuse OF Olanzapine by Substance AbusersJournal of Psychoactive Drugs, 2007
- Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderBritish Journal of Pharmacology, 2006
- Treatment of glossodynia with olanzapineJournal of the American Academy of Dermatology, 2004